Pharmaceutical Technology Europe-03-01-2012

News
Pharmaceutical Technology Europe

March 01, 2012

The pharma industry has reached the long-dreaded patent cliff, but for copycat products, business is booming.

Pharmaceutical Technology Europe
Industry Insider

March 01, 2012

Traditionally more prevalent in less industrialised regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries.

Pharmaceutical Technology Europe

Boehringer Ingelheim's Heribert Häusler tells us about parametric release and real-time testing.

Peer-Reviewed Research
Pharmaceutical Technology Europe

March 01, 2012

In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.

Ingredients
Pharmaceutical Technology Europe

March 01, 2012

Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

Outsourcing Review
Pharmaceutical Technology Europe

March 01, 2012

The evolving bio/pharmaceutical business model poses risk for CMOs.

Pharmaceutical Technology Europe
Special Feature

March 01, 2012

The authors describe a new assembly for bulk and final drug product filling operations.